Oklahoma SB1427: Public health; mandating certain pediatric screenings for type 1 diabetes; providing for certain reimbursement and funding. Effective date.

What the bill says

An Act relating to public health; authorizing health care providers to conduct pediatric screenings for type 1 diabetes subject to parental consent; providing for certain reimbursement; directing the State Department of Health to seek certain funding; directing promulgation of rules; providing for codification; and providing an effective date. SUBJECT: Pediatric diabetes screening.

From the enrolled text, April 30, 2026:

An Act relating to public health; authorizing health care providers to conduct pediatric screenings for type 1 diabetes subject to parental consent; providing for certain reimbursement; directing the State Department of Health to seek certain funding; directing promulgation of rules; providing for codification; and providing an effective date. SUBJECT: Pediatric diabetes screening SECTION 1. NEW LAW A new section of law to be codified in the Oklahoma Statutes as Section 1-581 of Title 63, unless there is created a duplication in numbering, reads as follows: A. Every health care provider in this state may conduct pediatric screenings for type 1 diabetes in accordance with accepted medical practices and subject to the informed consent of the child's parent or legal guardian. B. The screenings described in subsection A of this section shall be reimbursable under the state Medicaid program, subject to receipt of any necessary federal approval and in accordance with rules promulgated by the Oklahoma Health Care Authority Board. C. The State Department of Health shall seek grants and other funding opportunities to support the provision of pediatric screenings for type 1 diabetes as described in subsection A of this section. D. The Oklahoma Health Care Authority Board shall promulgate rules necessary to implement subsection B of this section. SECTION 2. This act shall become effective November 1, 2026. ENR. …

Read the full official text

Sponsors

• Jared Deck (D, HD-044)
• Carri Hicks (D, SD-040) · primary sponsor

Latest actions

1. May 7, 2026: Becomes law without Governor's signature 05/07/2026
2. April 30, 2026: Sent to Governor
3. April 30, 2026: Signed, returned to Senate
4. April 30, 2026: Enrolled, to House
5. April 29, 2026: Referred for enrollment
6. April 29, 2026: Signed, returned to Senate
7. April 29, 2026: Third Reading, Measure passed: Ayes: 84 Nays: 0
8. April 29, 2026: General Order
9. April 23, 2026: Coauthored by Representative(s) Deck
10. April 23, 2026: CR; Do Pass Appropriations and Budget Committee

Votes

• Third Reading (April 29, 2026): 84 yea, 0 nay, passed
• Floor Vote (April 21, 2026): 24 yea, 0 nay, passed
• Floor Vote (April 6, 2026): 6 yea, 0 nay, passed
• Third Reading (March 25, 2026): 43 yea, 2 nay, passed
• Floor Vote (March 25, 2026): 43 yea, 0 nay, failed
• Senate Health & Human Services Committee (February 16, 2026): 9 yea, 3 nay, passed

Common questions

What is SB1427?

SB1427 is a bill in the Oklahoma Legislature (2026 Regular Session): Public health; mandating certain pediatric screenings for type 1 diabetes; providing for certain reimbursement and funding. Effective date.

What does SB1427 do?

In its own words: An Act relating to public health; authorizing health care providers to conduct pediatric screenings for type 1 diabetes subject to parental consent; providing for certain reimbursement; directing the State Department of Health to seek certain funding; directing promulgation of rules; providing for codification; and providing an effective date. SUBJECT: Pediatric diabetes screening.

What is the status of SB1427?

Chaptered as of May 7, 2026. Latest action: Becomes law without Governor's signature 05/07/2026 (May 7, 2026).

Who sponsored SB1427?

Carri Hicks (D, SD-040), with 1 co-sponsor.

Where is the official record for SB1427?

On the Oklahoma Legislature website: https://www.oklegislature.gov/BillInfo.aspx?Bill=SB1427&Session=2600